Neurodazine
SIGMA/N6664 - ≥98% (HPLC)
Synonym: 2-
CAS Number: 937807-66-4
Empirical Formula (Hill Notation): C27H21ClN2O3
Molecular Weight: 456.92
MDL Number: MFCD08906055
Linear Formula: C27H21ClN2O3
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | yellow |
| form | powder |
| InChI | 1S/C27H21ClN2O3/c1-31-21- |
| InChI key | FEEOFPAEDSMOTO-UHFFFAOYSA |
| Quality Level | 100  |
| SMILES string | COc1ccc(cc1)-c2nc([nH]c2- |
| solubility | DMSO: >20 mg/mL |
| storage temp. | −20°C |
| Biochem/physiol Actions: | Neurodazine is a promoter of neurogenesis. It induces a generation of new nerve cells from skeletal muscle fibers both immature, differentiated myotubes and mature skeletal muscle. Neurodazine promotes the expression of neuron-specific markers in treated C2C12 cells (neurogenesis). In addition, in conjunction with a microtubule-destabilizing agent, Neurodazine allows neurogenic conversion of both differentiated immature myotubes and mature skeletal muscle. Neurodazine is a potential alternative approach to using stem cells. |
| Biochem/physiol Actions: | Neurodazine is a promoter of neurogenesis; induces generation of new nerve cells from skeletal muscle fibers both immature differentiated myotubes and mature skeletal muscle; a potential alternative approach to using stem cells. |
| Packaging: | 5, 25 mg in glass bottle |
| Symbol |   GHS05,GHS06 |
| Signal word | Danger |
| Hazard statements | H301 - H318 - H413 |
| Precautionary statements | P280 - P301 + P310 - P305 + P351 + P338 |
| Hazard Codes | T |
| Risk Statements | 25-41 |
| Safety Statements | 26-39-45 |
| RIDADR | UN 2811 6.1 / PGIII |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |